$204 Million is the total value of Invus Financial Advisors, LLC's 8 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OYST | Oyster Point Pharma Inc | $90,651,000 | +43.2% | 2,590,015 | 0.0% | 44.50% | +38.6% | |
| YEXT | Yext Inc | $42,256,000 | -29.3% | 4,146,784 | 0.0% | 20.74% | -31.6% | |
| NVCR | Novocure Ltd | $31,709,000 | -20.1% | 470,884 | 0.0% | 15.57% | -22.6% | |
| RCUS | Arcus Biosciences Inc | $25,568,000 | +37.4% | 1,842,077 | 0.0% | 12.55% | +33.0% | |
| UBX | Unity Biotechnology Inc | $12,702,000 | -19.6% | 2,189,998 | 0.0% | 6.24% | -22.1% | |
| CHGG | New | Chegg Inc | $353,000 | – | 9,868 | +100.0% | 0.17% | – |
| BABA | New | Alibaba Group Hldg Ltdsponsored ads | $236,000 | – | 1,211 | +100.0% | 0.12% | – |
| RUN | New | Sunrun Inc | $219,000 | – | 21,657 | +100.0% | 0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Arcus Biosciences Inc | 16 | Q3 2023 | 24.7% |
| Novocure Ltd | 16 | Q3 2023 | 25.4% |
| Oric Pharmaceuticals Inc | 14 | Q3 2023 | 14.3% |
| Oyster Point Pharma Inc | 13 | Q4 2022 | 44.5% |
| Coupang Inc | 11 | Q3 2023 | 51.6% |
| Taboola.com Ltd | 10 | Q3 2023 | 23.7% |
| Unity Biotechnology Inc | 9 | Q4 2021 | 8.0% |
| Yext Inc | 8 | Q3 2021 | 30.3% |
| IONQ Inc | 8 | Q3 2023 | 7.2% |
| Nu Hldgs Ltd | 6 | Q3 2023 | 25.4% |
View Invus Financial Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Invus Financial Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.